FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
FDA General

Hahns FDA Nomination Heads to Full Senate

Senate Health, Education, Labor & Pensions Committee votes 18 to 5 to advance Stephen Hahns nomination to serve as FDA commissioner to the full Senate...

Federal Register

Guide on Drug Trial Adaptive Designs

Federal Register notice: FDA makes available a final guidance entitled Adaptive Designs for Clinical Trials of Drugs and Biologics.

Medical Devices

Lawmakers Push for UDIs on Insurance Forms

Five bipartisan members of Congress ask HHS and CMS to include unique device identifiers on health insurance claims forms to enhance post-market surve...

Human Drugs

Nubratori Rx FDA-483

FDA releases the FDA-483 with three observations from an inspection at Nubratori, Inc.

Human Drugs

Immunomedics Re-files for Breast Cancer Therapy

Immunomedics resubmits its BLA seeking accelerated approval for sacituzumab govitecan, indicated for treating certain patients with metastatic triple-...

FDA General

Judicial Deference to FDA More Uncertain: Analysis

A Ropes&Gray legal analysis says a recent Supreme Court decision could make it easier for regulated companies to argue against court granting deferenc...

Human Drugs

3rd Circuit Remands Hundreds of Fosamax Cases

The 3rd Circuit Court of Appeals asks a New Jersey federal court to look at hundreds of Fosamax bone fracture cases and determine whether they are pre...

Medical Devices

NeuroOne Thin Film Brain Electrode Cleared

FDA clears a NeuroOne Medical Technologies 510(k) to market its thin film cortical electrode technology for temporary (less than 30 days) recording, m...

Human Drugs

Immunomedics Re-files for Breast Cancer Therapy

Immunomedics resubmits its BLA seeking accelerated approval for sacituzumab govitecan, indicated for treating certain patients with metastatic triple-...

Human Drugs

Merck sBLA Accepted for Keytruda in Bladder Cancer

FDA accepts for priority review a Merck supplemental BLA for Keytruda (pembrolizumab), Mercks anti-PD-1 therapy as monotherapy for treating patients w...